Skip to main content

Laura Ferris

Specialist

  • Medicare participating

At a glance

Years since graduation
24
In the NPI registry since
2006
Medicare patients seen, 2024
224

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2002Medical school: University of Maryland School of Medicine
  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Specialist primary
    PA license MD426643

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
224
Services billed
513
Patients’ average age
73
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 20-29 minutes123109
Established patient office or other outpatient visit, 30-39 minutes9377
Destruction of precancer skin growth, 2-14 growths9223
Destruction of precancer skin growth, 1 growth5345
Biopsy of related skin growth, first growth4843
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm3131
Destruction of skin growth, 1-14 growths2219
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm1915
Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm1111

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Clobetasol Propionate
Other prescribers in Pittsburgh, PA
173
Triamcinolone Acetonide
Other prescribers in Pittsburgh, PA
155
Ketoconazole
Other prescribers in Pittsburgh, PA
132
Methotrexate (methotrexate sodium)
Other prescribers in Pittsburgh, PA
115
Tremfya (guselkumab)48
Fluorouracil
Other prescribers in Pittsburgh, PA
43
Skyrizi Pen (risankizumab-rzaa)43
Skyrizi (risankizumab-rzaa)36
Humira(Cf) Pen (adalimumab)
Other prescribers in Pittsburgh, PA
36
Taltz Autoinjector (ixekizumab)34

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 21 companies reported 82 payments worth $84,499 in total to this clinician.

By type
Consulting Fee$51,833
Travel and Lodging$17,529
Compensation for services other than consulting (speaking, faculty)$12,237
Food and Beverage$2,901

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Sep 19, 2025Boehringer Ingelheim Pharma GmbH & Co.kg
Sep 19, 2025
Travel and Lodging
travel to Paris, France · in-kind
$9,628
Jul 12, 2025Janssen Biotech, Inc.
Jul 12, 2025
Consulting Fee
TREMFYA · Immunology
$8,100
Oct 22, 2025Boehringer Ingelheim International GmbH
Oct 22, 2025
Compensation for services other than consulting (speaking, faculty)$6,900
Apr 4, 2025Regeneron Pharmaceuticals, Inc.
Apr 4, 2025
Consulting Fee
LIBTAYO · ONCOLOGY
$6,685
Aug 18, 2025Pfizer Inc.
Aug 18, 2025
Consulting Fee
LITFULO · IMMUNOLOGY
$6,200
Sep 30, 2025E.r. Squibb & Sons, L.l.c.
Sep 30, 2025
Consulting Fee$5,968
Mar 13, 2025Arcutis Biotherapeutics, Inc.
Mar 13, 2025
Consulting Fee
Zoryve · Dermatology
$4,875
Feb 11, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Feb 11, 2025
Consulting Fee
SPEVIGO · IMMUNOLOGY
$3,850
Mar 13, 2025Arcutis Biotherapeutics, Inc.
Mar 13, 2025
Travel and Lodging
Zoryve · Dermatology · travel to Irving, TX
$3,750
Feb 17, 2025Sun Pharmaceutical Industries Inc.
Feb 17, 2025
Consulting Fee
ILUMYA · Dermatology
$3,250
All 33 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Nov 24, 2025Almirall LLC
Nov 24, 2025
Consulting Fee
Klisyri; Seysara · Dermatology
$1,275
Nov 19, 2025Almirall LLC
Nov 19, 2025
Consulting Fee
Seysara; Klisyri · Dermatology
$1,700
Nov 13, 2025UCB, Inc.
Nov 13, 2025
Consulting Fee
Bimzelx · Immunology
$2,400
Oct 22, 2025Boehringer Ingelheim International GmbH
Oct 22, 2025
Compensation for services other than consulting (speaking, faculty)$6,900
Oct 22, 2025Boehringer Ingelheim International GmbH
Oct 22, 2025
Consulting Fee$2,850
Oct 22, 2025Boehringer Ingelheim International GmbH
Oct 22, 2025
Travel and Lodging
travel to Paris, France · in-kind
$158
Sep 30, 2025E.r. Squibb & Sons, L.l.c.
Sep 30, 2025
Consulting Fee$5,968
Sep 19, 2025Boehringer Ingelheim Pharma GmbH & Co.kg
Sep 19, 2025
Travel and Lodging
travel to Paris, France · in-kind
$9,628
Sep 19, 2025Boehringer Ingelheim Pharma GmbH & Co.kg
Sep 19, 2025
Compensation for services other than consulting (speaking, faculty)$2,037
Sep 19, 2025Boehringer Ingelheim Pharma GmbH & Co.kg
Sep 19, 2025
Travel and Lodging
travel to Paris, France · in-kind
$674
Sep 12, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Sep 12, 2025
Compensation for services other than consulting (speaking, faculty)
SPEVIGO · IMMUNOLOGY
$2,500
Aug 18, 2025Pfizer Inc.
Aug 18, 2025
Consulting Fee
LITFULO · IMMUNOLOGY
$6,200
Jul 12, 2025Janssen Biotech, Inc.
Jul 12, 2025
Consulting Fee
TREMFYA · Immunology
$8,100
Jun 27, 2025Janssen Biotech, Inc.
Jun 27, 2025
Travel and Lodging
TREMFYA · Immunology · travel to PHILADELPHIA, PA · in-kind
$525
Jun 27, 2025Takeda Pharmaceuticals U.S.A., Inc.
Jun 27, 2025
Travel and Lodging
travel to CHICAGO, IL · in-kind
$337
Jun 27, 2025Janssen Biotech, Inc.
Jun 27, 2025
Travel and Lodging
TREMFYA · Immunology · travel to PHILADELPHIA, PA · in-kind
$243
Jun 27, 2025Takeda Pharmaceuticals U.S.A., Inc.
Jun 27, 2025
Travel and Lodging
travel to CHICAGO, IL · in-kind
$205
Jun 26, 2025Takeda Pharmaceuticals U.S.A., Inc.
Jun 26, 2025
Travel and Lodging
travel to CHICAGO, IL · in-kind
$316
Jun 26, 2025Takeda Pharmaceuticals U.S.A., Inc.
Jun 26, 2025
Travel and Lodging
travel to CHICAGO, IL · in-kind
$300
Jun 7, 2025Arcutis Biotherapeutics, Inc.
Jun 7, 2025
Consulting Fee
Zoryve · Dermatology
$750
Apr 4, 2025Regeneron Pharmaceuticals, Inc.
Apr 4, 2025
Consulting Fee
LIBTAYO · ONCOLOGY
$6,685
Apr 4, 2025Regeneron Pharmaceuticals, Inc.
Apr 4, 2025
Consulting Fee
LIBTAYO · ONCOLOGY
$955
Apr 2, 2025Almirall LLC
Apr 2, 2025
Consulting Fee
Seysara; Klisyri · Dermatology
$2,975
Mar 13, 2025Arcutis Biotherapeutics, Inc.
Mar 13, 2025
Consulting Fee
Zoryve · Dermatology
$4,875
Mar 13, 2025Arcutis Biotherapeutics, Inc.
Mar 13, 2025
Travel and Lodging
Zoryve · Dermatology · travel to Irving, TX
$3,750
Mar 5, 2025Almirall LLC
Mar 5, 2025
Compensation for services other than consulting (speaking, faculty)$800
Feb 26, 2025E.r. Squibb & Sons, L.l.c.
Feb 26, 2025
Travel and Lodging
travel to JERSEY CITY, NJ
$143
Feb 21, 2025Arcutis Biotherapeutics, Inc.
Feb 21, 2025
Travel and Lodging
Zoryve · Dermatology · travel to Irving, TX · in-kind
$568
Feb 17, 2025Sun Pharmaceutical Industries Inc.
Feb 17, 2025
Consulting Fee
ILUMYA · Dermatology
$3,250
Feb 11, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Feb 11, 2025
Consulting Fee
SPEVIGO · IMMUNOLOGY
$3,850
Feb 11, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Feb 11, 2025
Travel and Lodging
SPEVIGO · IMMUNOLOGY · travel to Ridgefield, CT · in-kind
$140
Feb 7, 2025E.r. Squibb & Sons, L.l.c.
Feb 7, 2025
Travel and Lodging
travel to Jersey City, NJ
$262
Feb 6, 2025E.r. Squibb & Sons, L.l.c.
Feb 6, 2025
Travel and Lodging
travel to Jersey City, NJ
$279

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Pennsylvania →

Industry-funded research

Named as a principal investigator on 7 industry-funded studies in 2025, from 6 companies. The companies reported $147,066 in research payments for these studies, mostly to the institutions running them.

  • TAK-279-PsO-3004 A Phase 3, multi-center, head to head Study To Evaluate The Efficacy, Safety, And Tolerability of TAK-279 in Subjects With Moderate to Severe Plaque Psoriasis
    Takeda Pharmaceuticals U.S.A., Inc.
  • A Multicenter, Open Registry of Patients With Plaque Psoriasis Who Are Candidates for Systemic Therapy Including Biologics
    Janssen Research & Development, LLC
  • A Phase 1b, Randomized, Vehicle-Controlled, Double-Blind, Pharmacokinetics, Pharmacodynamics, and Safety Study of ARQ-255 Topical Suspension in Healthy Volunteers and Subjects with Alopecia Areata
    Arcutis Biotherapeutics, Inc.
  • A Phase 3, Multicenter, Double-blind Maintenance Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASC…
    Amgen Inc.
  • A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, EfficacyAnd Safety of Ruxolitinib Cream in Participants with Prurigo Nodularis
    Incyte Corporation
  • A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
    Eli Lilly and Company · Completed · NCT03570749
  • An Open-Label, Single-Arm, Phase 4 Study of Ruxolitinib Cream in Adults With Atopic Dermatitis Experiencing Sleep Disturbance in the United States (MORPHEUS)
    Incyte Corporation

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Specialist clinicians in Pittsburgh

Sources

NPI registry (CMS NPPES, November 2026; record last updated March 25, 2021), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1043283229. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.